Amgen bought Ch...
login
Shares
Bonds
π₯Pre-IPO
Dividends
Portfolio
More
ETF
Sectors
News
Calendar
Try for free
Login
×
Email
Password
Forgot your password?
Login
Resend my activation email
Need an account? Sign up.
Home
News
ChemoCentryx
Amgen bought ChemoCentryx
10/20/22 at 16:16
Share at
Vladimir Petenev
News editor
press@blackterminal.com
Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.
ChemoCentryx
Review
Source:
investors.amgen.com
Vladimir Petenev
News editor
Share at:
Share this news
×
To leave a comment, you must be logged in
Write your comment first
News feed
TGC-1 reduced electricity generation by 3.44% in the first quarter
4/25/23
TGKA
Kimberly-Clark reported for 3 months of 2023
4/25/23
KMB
Biogen reported for 3 months of 2023
4/25/23
BIIB
Verizon reported for 3 months of 2023
4/25/23
VZ
McDonald's reported for 3 months of 2023
4/25/23
MCD
PulteGroup reported for 3 months of 2023
4/25/23
PHM
3M reported for 3 months of 2023
4/25/23
MMM
General Motors reported for 3 months of 2023
4/25/23
GM
General Electric reported for 3 months of 2023
4/25/23
GE
PepsiCo profits in Q1 decreased 2.2 times
4/25/23
PEP
«
Previous
642
643
644
645
646
647
648
649
650
651
»
Next
BlackTerminal.com 2016 - 2025.
English (US)
English (US)
Π ΡΡΡΠΊΠΈΠΉ (Π Π€)